Table 1.
First passage (16/16a) | Second passage | Third passage | |||||
---|---|---|---|---|---|---|---|
15/16b | 457 ± 21.1c | → | 5/5 | 255.8 ± 28.8 | → | 10/10 | 151.5 ± 5.6 |
1/16d | 469 | → | 5/5 | 287.0 ± 6.5 | → | 10/10 | 272.3 ± 29.0 |
aNumber of infected mice/number of inoculated mice
bMice exhibiting weight loss and hind-limb ataxia. All of these mice showed the same clinical signs and same neuropathological phenotype. The brain homogenate of 1 of the 15 mice was used for the second passage (incubation period, 463 days)
cAverage ± standard deviation (days)
dA single mouse exhibiting polydipsia, polyuria, and obesity